John Carroll at Endpoints, a news website that covers the biotech and pharmaceutical industries, sent out an email poll to his industry readers about President Trump's travel ban on seven Muslim-majority countries. They're clearly outraged:
- 87% did not support the executive order.
- 74% thought it would have an impact on the biotech industry.
- A handful of biotech CEOs sent in their responses. One called the ban "deeply repugnant to the fundamental tenets and values of not only the United States but also the biotechnology industry." Another said it was "frightening and destructive."